Provided by Tiger Trade Technology Pte. Ltd.

Loews

108.68
+0.43000.40%
Pre-market: 109.390.7100+0.65%07:14 EDT
Volume:716.35K
Turnover:77.79M
Market Cap:22.22B
PE:13.32
High:108.93
Open:107.66
Low:107.66
Close:108.25
52wk High:121.01
52wk Low:95.71
Shares:204.43M
Float Shares:164.40M
Volume Ratio:0.82
T/O Rate:0.44%
Dividend:0.25
Dividend Rate:0.23%
EPS(TTM):8.16
EPS(LYR):7.97
ROE:9.31%
ROA:1.91%
PB:1.16
PE(LYR):13.63

Loading ...

Press Release: Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Dow Jones
·
Sep 08

Loews Declares BRL 0.22 Dividend Per Unit, Payable Sept. 8

Reuters
·
Sep 03

Why Alarming Bond Yields Might Drop Sooner than Investors Think

Dow Jones
·
Sep 03

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 03

Pyxis Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 01

Who is Rob Bonta? The AG at the heart of some of the biggest legal battles in business

CNN Business
·
Sep 01

Press Release: CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

Dow Jones
·
Aug 31

Loews Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 28

Press Release: CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

Dow Jones
·
Aug 27

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

GlobeNewswire
·
Aug 27

Khaled Al-Dhafer and Brothers Logistics Services H1 Loss SAR 4.2 Million

Reuters
·
Aug 26

Loews (L) Cools After A Mixed Stretch, Is The Stock Above Fair Value?

Simply Wall St.
·
Aug 25

BioNTech (BNTX) Is Up 27.3% After Novel Pumitamig Combo Data in Lung Cancer – Has The Bull Case Changed?

Simply Wall St.
·
Aug 24

BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

GlobeNewswire
·
Aug 20

Loews Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 20

Press Release: Kelun-Biotech Announces 2026 Interim Results

Dow Jones
·
Aug 17

Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

GlobeNewswire
·
Aug 14

Press Release: Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Dow Jones
·
Aug 13

Press Release: Theriva(TM) Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results

Dow Jones
·
Aug 11

Loews Declares BRL 0.22 Per Unit Distribution, Payable Sept. 8

Reuters
·
Aug 06